ArticleFrontiers in artificial intelligence2026
Acentric artificial intelligence with deep feature engineering for early heart disease risk prediction.
Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early identification of heart disease is important to reduce mortality rates and to provide timely medical intervention for better patient outcomes. In recent studies, machine learning has been used to predict cardiovascular risk, but many existing models use basic feature sets and fixed decision rules. This can limit their ability to adapt when new data are introduced and may also reduce their capability to detect early signs of risk. In this study, we present a heart disease prediction framework that integrates acentric artificial intelligence (Ac-AI) with deep feature engineering to improve prediction accuracy. We adopted an autoencoder-based representation learning module to learn compact latent features from clinical data. These learned features were then combined with the original variables to provide a more informative set of inputs for subsequent analyses. The Ac-AI classifier applies cost-sensitive learning and an adaptive decision threshold to improve sensitivity for disease classes. Across multiple experiments conducted on a benchmark heart disease dataset, the proposed model showed performance comparable to that of random forest (RF), support vector machine (SVM), and XGBoost. In some runs, it performed better than these baseline models. Repeated independent runs provided evidence that the method produced consistent results across trials. These results suggest that Ac-AI combined with deep feature engineering can serve as a useful decision support framework for the early prediction of heart disease risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.